companydata.dkcompanydata.dk

PEROZIN ApS: Financial statements 2025

CVR: 29183910

Source: annual report 2025, Danish Business Authority

01/05/2024 – 30/04/2025

PEROZIN ApS (CVR 29183910) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,799,719 and a net result of DKK 1,026,124 compared with DKK 736,080 the year before. That is an increase of 51.6% compared with the year before. Equity in the 2025 report amounted to DKK 9,644,024. The solvency ratio was 66.8%. The company had 1 employee in the financial year.

Gross Profit
DKK 2,799,719
Profit/Loss
DKK 1,026,124
Equity
DKK 9,644,024
Total Assets
DKK 14,439,853
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-2.8 mio.1 mio.9.6 mio.1
2024-1.8 mio.736 t.8.6 mio.1
2023-1.6 mio.904 t.7.9 mio.1
2022-2 mio.1000 t.7 mio.2
2020-950 t.14 t.5.6 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PEROZIN ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About PEROZIN ApS

PEROZIN ApS is a Danish company of the type Anpartsselskab based in Haslev, founded in 2005. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Gerard Gerner Hansen. The company is owned by GEBAL Holding ApS, Barghoth Ala Hasan Ali and Ehsan Ahmed Mousa Abdalla Elfarra. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 2,799,719 and a net result of DKK 1,026,124 compared with DKK 736,080 the year before. Equity in the 2025 report amounted to DKK 9,644,024.

Source: annual report 2025, Danish Business Authority